Title : β2-adrenoreceptor medications and risk of Parkinson disease.

Pub. Date : 2018 Nov

PMID : 30225948






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: A recent study observed a 2-fold greater risk of Parkinson disease (PD) in relation to the beta2-adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the beta2-adrenoreceptor agonist salbutamol. Propranolol adrenoceptor beta 2 Homo sapiens